Skip to main content

Advertisement

SpringerLink
Log in

Late outcomes of colorectal cancer treatment: a FECS-EUROCARE study

  • Published:
Journal of Cancer Survivorship Aims and scope Submit manuscript

Abstract

Background

Colorectal cancer survival has increased in recent years, however, the impact of these cancers and their treatment on long-term survivors has not been extensively investigated at the population level. This pilot study assessed the prevalence of late outcomes in long-term colorectal cancer survivors registered by two European population-based cancer registries (CRs) to determine the feasibility of using the approach on a wider basis in Europe.

Methods

Long-term survivors diagnosed in 1990 and in 1997 in Côte d’Or (France) and Varese (Italy) CRs were surveyed. Questionnaires to general practitioners (GPs) and survivors investigated a wide range of outcomes. Information on stage at diagnosis, primary treatment, stoma inserted during main surgery, and vital status was available from a previous study. Logistic regression was used to identify associations of late outcomes with sex, age at survey, country, year of diagnosis, and site.

Results

Participation was 51.8% (45.2% of French and 56.6% of Italian cases identified). Of the 256 survivors available for analysis, 10% had bowel incontinence, about 70% had other bowel, gastrointestinal, or urination problems, 10% had second primary cancer, 4% had colorectal recurrence, and 10% had stoma. The proportion with stoma reduced by 65% in survivors diagnosed between 1990 and 1997, but no other outcomes reduced in prevalence with time. Most (67%) had optimal GP-assessed ECOG performance status. Around 80% were followed-up with liver imaging or colonoscopy.

Conclusions

We identified non-trivial rates of bowel and bladder problems after colorectal treatment, but overall good levels of functioning. High-resolution studies of this kind must be population-based to provide data useful for public health provision. This pilot study encountered difficulties in contacting GPs and suffered from low compliance. However, it is the first to investigate late outcome trends after treatment for colorectal cancer.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Boyle P, Ferlay J. Cancer incidence and mortality in Europe, 2004. Ann Oncol. 2005;16(3):481–8.

    Article  PubMed  CAS  Google Scholar 

  2. Roazzi P, Capocaccia R, Santaquilani M, Carrani E. Electronic availability of EUROCARE-3 data: a tool for further analysis. Ann Oncol. 2003;14(Suppl 5):v150–5.

    Article  PubMed  Google Scholar 

  3. Faivre-Finn C, Bouvier-Benhamiche AM, Phelip JM, Manfredi S, Dancourt V, Faivre J. Colon cancer in France: evidence for improvement in management and survival. Gut. 2002;51(1):60–4.

    Article  PubMed  CAS  Google Scholar 

  4. Micheli A, Mugno E, Krogh V, Quinn MJ, Coleman MP, Hakulinen T, Gatta G, Berrino F, Capocaccia R, and the EUROPREVAL Working Group. Cancer prevalence in European registry areas. Ann Oncol. 2002;13:840–65.

    Article  PubMed  CAS  Google Scholar 

  5. Oken MM, Creech RH, Tormey DC, Horton J, Davis,TE, McFadden ET, Carbone PP. Toxicity and response criteria of the Eastern Cooperative Oncology Group. Am J Clin Oncol. 1982;5:649–55.

    Article  PubMed  CAS  Google Scholar 

  6. Gatta G, Capocaccia R, Sant M, Bell CMJ, Coebergh JWW, Damhuis RAM, et al. Understanding variations in colorectal cancer survival in Europe: a EUROCARE high-resolution study. Gut. 2000;47:533–8.

    Article  PubMed  CAS  Google Scholar 

  7. World Health Organisation. International Classification of Diseases, 1975, 9th edition. Geneva: WHO; 1997.

    Google Scholar 

  8. P. Hermanek, LH Sobin (eds). TNM Classification of Malignant Tumours, Fourth Edition, 2nd Revision 1992. UICC, International Union Against Cancer, Springer.

  9. Sprangers MA, te Velde A, Aaronson NK. The construction and testing of the EORTC colorectal cancer-specific quality of life questionnaire module (QLQ-CR38). European Organization for Research and Treatment of Cancer Study Group on Quality of Life. Eur J Cancer. 1999;35(2):238–47.

    Article  PubMed  CAS  Google Scholar 

  10. StataCorp. Stata Statistical Software: Release 7.0. College Station, TX: Stata Corporation; 2001.

    Google Scholar 

  11. Trentham-Dietz A, et al. Health-related quality of life in female long-term colorectal cancer survivors. The Oncologist. 2003;8:342–9.

    Article  PubMed  CAS  Google Scholar 

  12. Ramsey DS, et al. Quality of life in survivors of colorectal carcinoma. Cancer. 2000;88(6):1294–303.

    Article  PubMed  CAS  Google Scholar 

  13. Ramsey DS, et al. Quality of life in long term survivors of colorectal cancer. Am J Gastroenterol. 2002;97(5):1228–34.

    Article  PubMed  Google Scholar 

  14. Kirwan WO, O’Riordain MG, Waldron R. Declining indications for abdominoperineal resections. Br J Surg. 1989;76:1061–3.

    Article  PubMed  CAS  Google Scholar 

  15. Finn-Faivre C, Maurel J, Benhamiche AM, Herbert C, Mitry E, Launoy G, Faivre J. Evidence of improving survival of patients with rectal cancer in France: a population based study. Gut. 1999;44:377–81.

    Article  PubMed  CAS  Google Scholar 

  16. Pollack J, Holm T, Cedermark B, Holmstrom B, Mellgren A. Long-term effect of preoperative radiation therapy on anorectal function. Dis Colon Rectum. 2006;49(3):345–52.

    Article  PubMed  Google Scholar 

  17. Lundby L, Krogh K, Jensen VJ, Gandrup P, Qvist N, Overgaard J, Laurberg S. Long-term anorectal dysfunction after postoperative radiotherapy for rectal cancer. Dis Colon Rectum. 2005;48(7):1343–9.

    Article  PubMed  Google Scholar 

  18. Manfredi S, Bouvier AM, Lepage C, Hatem C, Dancourt V, Faivre J. Incidence and patterns of recurrence after resection for cure of colonic cancer in a well defined population. Br J Surg. 2006;93(9):1115–22.

    Article  PubMed  CAS  Google Scholar 

  19. Gatta G, Capocaccia R, Berrino F, Ruzza M, Contiero P, and the EUROPREVAL Working Group. Colon cancer prevalence and estimation of differing care needs of colon cancer patients. Ann Oncol. 2004;15(7):1136–42.

    Article  PubMed  CAS  Google Scholar 

  20. Yabroff KR, Lawrence WF, Clauser S, Davis WW, Brown ML. Burden of illness in cancer survivors: findings from a population-based national sample. J Natl Cancer Inst. 2004;96(17):1322–30.

    Article  PubMed  Google Scholar 

  21. McCredie M, Macfarlane GJ, Bell J, Coates M. Second primary cancers after cancer of the colon and rectum in New South Wales, Australia, 1972–1991. Cancer Epidemiol Biomarkers Prev. 1997;6(3):155–60.

    PubMed  CAS  Google Scholar 

  22. Hoar SK, Wilson J, Blot WJ, McLaughlin JK, Winn DM, Kantor AF. Second cancer following cancer of the digestive system in Connecticut, 1935–82. Natl Cancer Inst Monogr. 1985;68:49–82.

    PubMed  CAS  Google Scholar 

  23. Enblad P, Adami HO, Glimelius B, Krusemo U, Påhlman L. The risk of subsequent primary malignant diseases after cancers of the colon and rectum. Cancer. 1990;65:2091–100.

    Article  PubMed  CAS  Google Scholar 

  24. Burt RW. Familial risk and colorectal cancer. Gastroenterol Clin North Am. 1996;25(4):793–803.

    Article  PubMed  CAS  Google Scholar 

  25. Renehan AG, Egger M, Saunders MP, O’Dwyer ST. Impact on survival of intensive follow up after curative resection for colorectal cancer: systematic review and meta-analysis of randomised trials. BMJ. 2002;324(7341):813.

    Article  PubMed  Google Scholar 

  26. NIH Consensus Conference. Adjuvant therapy for patients with colon and rectal cancer. JAMA. 1990;264:1444–50.

    Article  Google Scholar 

Download references

Acknowledgements

We thank Don Ward for help with the English and Samba Sowe for editorial support. We also thank Ivana Marcatto and Maria Rosa Ruzza for tracing GPs and patients and managing contacts. We extend a special thanks to all GPs and patients who participated. The study was supported by the European Federation of Cancer Societies (FECS), the EUROCARE-3 BIOMED-2 Program, Contract No. BMH4-CT98-3390, and the Compagnia di San Paolo, Torino, Italy.

Author information

Authors and Affiliations

  1. Epidemiology Unit, Fondazione IRCCS “Istituto Nazionale Tumori”, Via Venezian 1, 20133, Milan, Italy

    Gemma Gatta, Laura Ciccolallo & Franco Berrino

  2. Registre Bourgignon des Cancers Digestifs, Faculté de Médicine, Dijon, France

    Jean Faivre & Anne-Marie Bouvier

  3. Department of Radiotherapy, Centre Antoine-Lacassagne, Nice, France

    Jean Pierre Gerard

Authors
  1. Gemma Gatta
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Laura Ciccolallo
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Jean Faivre
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Anne-Marie Bouvier
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Franco Berrino
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Jean Pierre Gerard
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Gemma Gatta.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Gatta, G., Ciccolallo, L., Faivre, J. et al. Late outcomes of colorectal cancer treatment: a FECS-EUROCARE study. J Cancer Surviv 1, 247–254 (2007). https://doi.org/10.1007/s11764-007-0030-1

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11764-007-0030-1

Keywords

Search

Navigation